stockrowCorbus Pharmaceuticals Holdings, Inc. (CRBP) vs MediciNova, Inc. (MNOV)
- Corbus Pharmaceuticals Holdings, Inc. CRBP 2.86 −19.89%
- MediciNova, Inc. MNOV 1.45 0.00%
Corbus Pharmaceuticals Holdings, Inc. and MediciNova, Inc. are both Biotechnology companies. MediciNova, Inc. is the larger, with a market value of $71.4M against $55.3M — 1.3× the size. Corbus Pharmaceuticals Holdings, Inc. grew revenue faster over the last twelve months: −73.7% against −82.2%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 16 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 9 and MediciNova, Inc. on 7.
Valuation
Profitability
| Metric | CRBP | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 37.76% | 65.16% |
| Operating margin | 0.00% | (1,287.53%) | 0.00% |
| Net margin | 0.00% | (1,168.31%) | 0.00% |
| Free cash flow margin | 0.00% | (991.31%) | 0.00% |
| Return on equity | (95.58%) | (25.56%) | (50.12%) |
| Return on assets | (80.85%) | (23.83%) | (45.60%) |
| Return on invested capital | 0.00% | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack